Tizanidine Tablet
Product Images NDC 63187-910

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 63187-910). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (3d3e6e45 9bae 48e9 B49a A4457541002e 01)

Chemical structure of Tizanidine hydrochloride, showing its molecular framework with a chloro-substituted benzothiazole ring connected to an imidazoline group.*

FDA Label Image

Figure-1 (3d3e6e45 9bae 48e9 B49a A4457541002e 02)

A pharmacokinetic line graph showing plasma Tizanidine concentration (ng/ml) on the vertical axis versus hours from dosing on the horizontal axis. The graph compares plasma levels over 24 hours for four groups: 4 mg Tizanidine tablets with food, 4 mg tablets without food, 4 mg capsules with food, and 4 mg capsules without food, each represented by distinct symbols and line styles, showing peak concentration around 1-2 hours post-dose and decline thereafter.*

FDA Label Image

Figure 3 (3d3e6e45 9bae 48e9 B49a A4457541002e 03)

A line graph showing improvement in Ashworth Score over time (hours post-dose) comparing 16 mg tizanidine, 8 mg tizanidine, and placebo. The vertical axis represents improvement in Ashworth Score, and the horizontal axis represents hours post-dose from 0 to 6. The graph includes error bars for each data point.*

FDA Label Image

Figure 4 (3d3e6e45 9bae 48e9 B49a A4457541002e 04)

A line graph depicting improvement in Ashworth Score over three time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). It compares two groups: tizanidine (mean dose 28.8 mg) shown with square markers, and placebo shown with circular markers, including error bars representing variability.*

FDA Label Image

Logo (3d3e6e45 9bae 48e9 B49a A4457541002e 05)

FDA Label Image

63187-910-60 (3d3e6e45 9bae 48e9 B49a A4457541002e 07)

Tizanidine 2 mg tablets label by Proficient Rx, package of 30. Each tablet contains 2.288 mg tizanidine hydrochloride equivalent to 2 mg tizanidine base. Tablets are described as white to off-white, round, flat, bevel edged, uncoated with specific imprints and bisecting score. Manufactured by Unichem Laboratories Ltd, India. Storage instructions and warnings about non-interchangeability with capsules are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.